
### [NCIT:C128044](http://purl.obolibrary.org/obo/NCIT_C128044)
**Label:** Cervical Low Grade Neuroendocrine Tumor, Grade 2

**Subclasses:** 

**Class expressions from DL-Learner:**

- [NCIT:C28078](http://purl.obolibrary.org/obo/NCIT_C28078) (Grade 2) 53.33%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C36855](http://purl.obolibrary.org/obo/NCIT_C36855) (Malignant Neuroendocrine Polygonal Cell))) 53.33%
- Thing 53.10%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) 38.69%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C3994](http://purl.obolibrary.org/obo/NCIT_C3994) (Stage IV Colon Cancer AJCC v6))) 38.69%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C3993](http://purl.obolibrary.org/obo/NCIT_C3993) (Stage II Colon Cancer AJCC v6))) 38.69%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C39914](http://purl.obolibrary.org/obo/NCIT_C39914) (Gain of Chromosome 12p))) 38.69%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C3991](http://purl.obolibrary.org/obo/NCIT_C3991) (Thrombocytopenia Due to Immune Destruction))) 38.69%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C39909](http://purl.obolibrary.org/obo/NCIT_C39909) (Gain of Chromosome 18q))) 38.69%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C39907](http://purl.obolibrary.org/obo/NCIT_C39907) (Seminal Vesicle Cystadenoma))) 38.69%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C39906](http://purl.obolibrary.org/obo/NCIT_C39906) (Seminal Vesicle Adenocarcinoma))) 38.69%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C39905](http://purl.obolibrary.org/obo/NCIT_C39905) (Prostate Stromal Proliferation of Uncertain Malignant Potential))) 38.69%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation))) 38.69%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C39902](http://purl.obolibrary.org/obo/NCIT_C39902) (Prostate Basal Cell Carcinoma))) 38.69%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma))) 38.69%


